Provenance du réseau au premier degré de Marcio Scorsin
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
MYOSIX SA
 MYOSIX SA BiotechnologyHealth Technology MYOSIX SA develops cell-based therapeutics. The company is involved in the development of autologous cell therapy products for the treatment of cardiopathies and certain forms of myopathy in humans. MYOSIX specializes in the development of cell-based therapeutics against other pathologies like cancers. MYOSIX is also engaged in a number of R&D projects and develops a cell and tissue bank for therapeutic or R&D purposes. The company was founded by Vilquin, Marolleau, Scorsin, Eisenmann and Halioua in 2000 and is headquartered in Saint-Germain-en-Laye, France.
4
| Private Company | Biotechnology | 4 |
Epygon SASU
 Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France.
3
| Subsidiary | Medical Specialties | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Marcio Scorsin via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Medical Specialties | Chief Executive Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | President | |
Arthur D. Little, Inc.
 Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AIRBUS SE | Aerospace & Defense | Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin | |
| THERADIAG | Medical Specialties | Chief Executive Officer | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
| MG Biotherapeutics LLC | Chief Operating Officer | ||
| Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree | |
| ESSEC Business School | College/University | Graduate Degree | |
| Université des Sciences et Technologies de Lille | College/University | Graduate Degree | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Truffle Capital SAS
 Truffle Capital SAS Investment ManagersFinance Truffle Capital SAS is an Independent Venture Capital firm founded in 2000. Truffle Capital is headquartered in Paris. | Investment Managers | Founder Private Equity Analyst | |
| CARMAT | Medical Specialties | Founder Chairman | |
| DEINOVE | Biotechnology | Founder | |
The EADS Group, Inc.
 The EADS Group, Inc. Engineering & ConstructionIndustrial Services The EADS Group, Inc. has grown since its founding in 1955 from a small, specialized firm to a multi-disciplined organization employing over 200 professionals. The EADS Group utilizes a customer-service approach. The staff at The EADS Group tackles every project with the client as the center focus. The EADS Group utilizes a customer-service approach. The staff at The EADS Group tackles every project with the client as the center focus. | Engineering & Construction | Chief Operating Officer | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
| Murigenetics SAS | Founder | ||
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | Director/Board Member | |
Maisons & Cités d'HLM
 Maisons & Cités d'HLM Real Estate DevelopmentFinance Maisons & Cités d'HLM provides real estate services. It offers builds social housing, as well as offers renting, selling, and buying of properties. The company was founded on December 31, 1985 and is headquartered in Douai, France. | Real Estate Development | Chairman | |
| Holding Incubatrice Medical Devices | Investment Managers | Chairman | |
Matra Défense SAS
 Matra Défense SAS Aerospace & DefenseElectronic Technology Matra Défense SAS manufactures defense equipment. It also sells weapons and ammunitions. The company is headquartered in Blagnac, France. | Aerospace & Defense | Chief Executive Officer | |
| Conseil Stratégique pour l'Innovation | Chairman | ||
| Strategic Council on Business Attractiveness | Corporate Officer/Principal | ||
| Groupe de Sup de Co La Rochelle | College/University | Graduate Degree | |
Kardiozis SAS
 Kardiozis SAS Medical SpecialtiesHealth Technology Kardiozis SAS engages in radio diagnostic and radiotherapy activities. It also develops aortic stent. The company was founded on March 15, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Chairman | |
MBDA SAS
 MBDA SAS Financial ConglomeratesFinance MBDA SAS is an investment holding French company. The joint venture company is based in le Plessis Robinson, FR. and has subsidiaries in United Kingdom, Germany and Ireland. Éric Béranger has been the CEO of the company since 2019. | Financial Conglomerates | Comptroller/Controller/Auditor | |
Bioxodes SA
 Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Director/Board Member | |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| Artedrone SAS | Director/Board Member | ||
PDC Line Pharma SA
 PDC Line Pharma SA Pharmaceuticals: MajorHealth Technology Part of PDC Line Pharma SASU, PDC Line Pharma is a Belgian company that focuses on medical needs, particularly on skin cancer, which is the most lethal form of cancer worldwide. The company is based in Liege, Belgium, and has two drug candidates in its pipeline, one for melanoma and another for lung cancer. The company aims to address this issue by developing drug candidates that can bring positive results to patients. PDC Line Pharma was founded in 2016 by Laurent Levy and Joel Plumas, and its CEO is Eric Halioua. | Pharmaceuticals: Major | Chief Executive Officer | |
| French American Chamber of Commerce New England | Director/Board Member | ||
| Holistick Medical Sasu | Director/Board Member | ||
| Skinosive Sasu | Chairman | ||
| Pk Med SAS | Chairman | ||
| Caranx Medical SAS | Founder | ||
| Bariatek Medical SAS | Director/Board Member | ||
| Spikimm SAS | Chairman | ||
| BioCuster | Director/Board Member | ||
Demeta SAS
 Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| France | 33 |
| Etats-Unis | 13 |
| Belgique | 5 |
| Royaume-Uni | 2 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 6 |
| Finance | 5 |
| Electronic Technology | 3 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 48 |
| Founder | 25 |
| Chairman | 22 |
| Chief Executive Officer | 11 |
| Corporate Officer/Principal | 10 |
Relations les plus connectées
- Bourse
- Insiders
- Marcio Scorsin
- Connexions Sociétés
